Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
about
The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology groupImpact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body StudyDispositional and Situational Avoidance and Approach as Predictors of Physical Symptom Bother Following Breast Cancer Diagnosis.A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors.Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.Cognitive changes associated with endocrine therapy for breast cancer.Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.Outcomes of a weight loss intervention among rural breast cancer survivors.Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trialPatient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.Pretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.The effect of a community-based exercise intervention on symptoms and quality of life.Protocol and recruitment results from a randomized controlled trial comparing group phone-based versus newsletter interventions for weight loss maintenance among rural breast cancer survivorsWho participates in a randomized trial of mindfulness-based stress reduction (MBSR) after breast cancer? A study of factors associated with enrollment among Danish breast cancer patients.A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.Chronic and episodic stress predict physical symptom bother following breast cancer diagnosis.Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors.Effect of mindfulness-based stress reduction on somatic symptoms, distress, mindfulness and spiritual wellbeing in women with breast cancer: Results of a randomized controlled trial.Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.A randomized, double-blind, crossover trial comparing a silicone- versus water-based lubricant for sexual discomfort after breast cancer.
P2860
Q28680695-29D14650-E509-4766-912A-E4B8C67B56D6Q30758966-41B5AE48-40E1-4E57-AB88-83937A2AE264Q30823100-0A227D7E-A0AD-4045-AAB2-85DE3109E659Q33914381-4E8FE0B9-5C7B-45DA-BE8C-3D435857A7EBQ34574742-F9448BAB-BCB5-4FAE-AA78-8891CD98C7F3Q34877439-C73DBCF9-45A2-443F-A750-8FAC55A071C9Q35202213-1E726F9C-C906-4D94-B32B-EA5688DCC2D4Q35207952-E1576072-E0FE-4EC7-AE8D-CDF32CB2F9D3Q35234203-72858BC2-14F7-4F35-BF48-66C07303BAEDQ35660927-300D6543-508F-44AB-9EB1-06DD76E74AEDQ35846781-01B76159-F1A3-4C47-B8F9-270F8B77144FQ35857538-DCF3079D-93F9-4C40-A01F-8903224282BDQ36363405-1DC40239-2EB4-41AA-8E2B-50541DD3D68FQ36689309-B23C2432-2B80-4DBF-A029-46C6D699055FQ36884366-80631508-B1C5-4D39-9B27-2ED0A747753DQ37044668-4C61FE38-DC87-4DB8-BA00-915B31246F62Q37298737-29BADA1B-2754-43D1-AE29-17052F6116EEQ37374507-D774E3E6-58EB-491A-8D02-D42558C9C24FQ37711610-9D6EE341-1A0A-40B2-97A6-28F800CEBB96Q38471515-5FD0BE85-C51E-4ADF-BF25-E25D0793B63BQ38947105-EC3C2C68-B57D-4791-9D94-B602D9920ECDQ41983968-5F34F5E3-53CB-4AAB-9AD3-03E4E81A68BAQ46606896-544CC3B3-E204-45FD-99EE-2D870F577A95Q46783099-676C3123-D8D0-4DFE-9944-98963291D445Q47163929-4FDCF277-65C3-490A-8757-8E6FA153A6A0Q47255754-75D8C920-41C2-4A9F-A2E3-D7C7E3AEB85BQ48046612-5D1580B0-3C20-4430-85E6-0137356B12EDQ48904774-C8352CCA-017E-413E-8F17-481F6B2D7169Q48949954-3FF015C3-81BD-423B-B6CA-89DBECF84F86Q53779463-D66598E7-EB93-4078-BD2D-F66D5010A185
P2860
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Symptom measurement in the Bre ...... of symptoms for midlife women.
@en
type
label
Symptom measurement in the Bre ...... of symptoms for midlife women.
@en
prefLabel
Symptom measurement in the Bre ...... of symptoms for midlife women.
@en
P2093
P1476
Symptom measurement in the Bre ...... of symptoms for midlife women.
@en
P2093
Chih-Hung Chang
Joseph P Costantino
Norman Wolmark
Patricia A Ganz
Richard Day
Stephanie R Land
P2888
P304
P356
10.1007/S10549-007-9682-9
P407
P50
P577
2007-09-13T00:00:00Z
P6179
1016801949